P110 | ZANUBRUTINIB IN WALDENSTROM MACROGLOBULINEMIA. REPORT ON THE EXPERIENCE OF THE CAMPANIA GROUP ON CLL/WM: THE DIAGNOSTIC AND INTEGRATED DIRECTION FOR OPTIMIZED CAMPANIA NETWORKING IN WALDENSTROM DISEASE (DIDONE) PROJECT.

Waldenström macroglobulinemia (WM) is a rare lymphoplasmacytic lymphoma with immunoglobulin M (IgM) monoclonal protein whose clinical features include anemia, thrombocytopenia, hepatosplenomegaly, lymphadenopathy, and more rarely hyperviscosity. Bruton tyrosine kinase (BTK) inhibitors are approved i...

Full description

Bibliographic Details

Published in:	Haematologica
Main Authors:	G. D'arena, M. Lucignano, R. Fontana, G.R. Nunziata, F. Graziani, M. Troiano, V. Amico, A. Fresa, G. Svanera, L. Pezzullo, D. De Novellis, V. Sammartano, C. Giordano
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2025-09-01
Online Access:	https://haematologica.org/article/view/12407